October 16, 2026 05:10 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'How dare Elon Musk?' Owaisi defends Modi after billionaire's 'real boss' jibe at Ambani | 'B****y S***': IAS officer's abuse of female colleague during virtual J&K meeting sparks row | Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism | Meerut blue drum murder case: Muskaan, her lover get death sentence | 'Rise up, young patriots!': American singer Mary Millben alleges CJP gets US funding, urges peaceful protests | 'Won't go unchallenged': Muhammad Yunus heckling in New York triggers legal action warning | flydubai cockpit attack probe widens: Two Maldivian pilots detained in UAE over links to Omani co-pilot
AstraZeneca
WIKIMEDIA COMMONS

WHO to hold meeting on AstraZeneca Vaccine safety on Tuesday

| @indiablooms | Mar 16, 2021, at 02:42 pm

Geneva/Sputnik: The World Health Organization's (WHO) global advisory committee on vaccine safety will hold a meeting on Tuesday on the safety of the AstraZeneca vaccine, WHO Director General Tedros Adhanom Ghebreyesus said.

"The WHO's advisory committee on vaccine safety has been reviewing the available data, is in close contact with the European Medicines Agency and will meet tomorrow," Tedros said at a briefing.

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has scheduled an extraordinary meeting for March 18, during which it intends to evaluate all recent incidents related to vaccinations with AstraZeneca, the regulator said.

"EMA’s safety committee (PRAC) will further review the information tomorrow (Tuesday) and has called an extraordinary meeting on Thursday 18 March to conclude on the information gathered and any further actions that may need to be taken," the statement says.

EMA also confirmed that during the investigation, the regulator proceeds from the position that the benefits of the AstraZeneca vaccine outweigh the risks associated with it.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.